Clobetasol Propionate Information
What's inside Clobetasol Propionate
Clobetasol Propionate Active Ingredients: clobetasol propionate, details.| Clobetasol Propionate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Clobetasol Propionate 0.05% | solution | topical | 100.0 milliliter(s) | OTC |
| Clobetasol Propionate 0.05% | ointment | topical | 100.0 gram(s) | OTC |
| Clobetasol Propionate 0.05% | cream | topical | 100.0 gram(s) | OTC |
| Clobetasol Propionate 0.05% | gel | topical | 100.0 gram(s) | OTC |
| Clobetasol Propionate - | powder | compounding | 100.0 gram(s) | OTC |
Recent Clobetasol Propionate Side Effects
Posted by keilah about 1 year ago
How can I read all the posted side effects?
Clobetasol Propionate in the News
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ... - PharmaLive.com (press release)
... Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; ...
Thu Mar 06 15:58:39 -0500 2008
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ... - Market Wire (press release)
... 1%; Luxiq ® (betamethasone valerate) Foam, 0.12%; MimyX ® ; Olux TM (clobetasol propionate) Foam, 0.05%; Olux-E TM (clobetasol propionate) Foam, 0.05%; ...
Thu Mar 06 06:32:43 -0500 2008
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ... - Trading Markets (press release)
... Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; ...
Thu Mar 06 06:34:23 -0500 2008
Clobetasol Propionate Chemical Information
clobetasol propionate - The propionate salt form of clobetasol, a topical synthetic corticosteroid with anti-inflammatory, anti-pruritic, and vasoconstrictive properties. Clobetasol propionate exerts its effect by binding to cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. This results in synthesis of certain anti-inflammatory proteins, while inhibiting the synthesis of certain inflammatory mediators. Specifically, clobetasol propionate appears to induce phospholipase A2 inhibitory proteins, thereby controlling the release of the inflammatory precursor arachidonic acid from membrane phospholipids by phospholipase A2.
Clobetasol Propionate RSS Feed